Clinical and laboratory findings in elderly with Community-Acquired Pneumonia in Babol, northern Iran – 2017-2019
PDF

Keywords

community-acquired pneumonia
elderly
clinical manifestation

Abstract

Morbidity and mortality are higher in older adults with community-acquired pneumonia (CAP) than in other age groups. Also, CAP in older adults has various clinical manifestations with other. A higher mortality rate in the elderly with CAP may contribute to a delay in management. Consequently, the purpose of this study was to investigate the clinical and laboratory manifestations of CAP in the elderly. This cross-sectional study was conducted on 221 elderly patients with CAP who were admitted to Ayatollah Rouhani Hospital, in Babol, northern of Iran, in 2017-2019. Patient outcomes included 170 cases that recovered from CAP, and 51 cases that died of complications. Patients were evaluated in terms of their clinical and laboratory manifestations. The most common symptoms of pneumonia were cough (79.6%), sputum (73.8%), weakness (72.9%), fever (56%), dyspnea (46.2%). The most frequent underlying disease was ischemic heart disease (43.9%). In our study, clinical and laboratory characteristics in older patients with CAP were evaluated and compared with other studies confirming past findings, but there were differences in some cases, such as vital signs, gastrointestinal symptoms, and disturbance of the level of consciousness. Therefore, it recommends carefully taking the patients’ initial histories and accurately recording their clinical and laboratory symptoms.
PDF

References

1. Mandell LA. Community-acquired Pneumonia: An overview. Postgrad Med. 2015;127(6):607-15.

2. Shokri M, Ghasemian R, Bayani M, Maleh PA, Kamrani M, Sadeghi-Haddad-Zavareh M, et al. Serum and alveolar procalcitonin had a weak diagnostic value for ventilator-associated pneumonia in patients with pulmonary infection score ≥ 6. Rom J Intern Med. 2018;56(1):9-14.

3. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated Pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infecti Dis. 2016;63(5):e61-e111.

4. Marrie TJ, Huang JQ. Epidemiology of community-acquired Pneumonia in Edmonton, Alberta: an emergency department-based study. Can Respir J. 2005;12(3):139-42.

5. Marrie TJ, Haldane EV, Faulkner RS, Durant H, Kwan C. Community‐acquired pneumonia requiring hospitalization: is it different in the elderly? J Am Geriatr Soc. 1985;33(10):671-80.

6. Fernández-Sabé N, Carratalà J, Rosón B, Dorca J, Verdaguer R, Manresa F, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine. 2003;82(3):159-69.

7. Gadsby NJ, Russell CD, McHugh MP, Mark H, Conway MA, Laurenson IF, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817-23.

8. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired Pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415-27.

9. Marrie TJ. Community-acquired Pneumonia. Clin Infecti Dis. 1994;18(4):501-13.

10. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia?: Diagnosing pneumonia by history and physical examination. JAMA. 1997;278(17):1440-5.

11. Vukkadala N, Auerbach A. Clinical utility of routine CBC testing in patients with community-acquired pneumonia. J Hosp Med. 2017;12(5):336-8.

12. Anevlavis S, Bouros D. Scoring systems in community acquired pneumonia. Pneumon. 2009;22(4):286-9.

13. España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174(11):1249-56.

14. Cheraghi M, Tavakol H, Tabatabaei S, Hashemi B. Clinical manifestation of patients with Acquired Pneumonia admitted in the respiratory ward of Imam Khomeini Hospital in Ahvaz. J Prev Med. 2014;1(1):51-7.

15. Momen-Heravi M, Razzaghi R, Mousavi G, Zamani-Fard S. Factors affecting the outcome of community-acquired pneumonia among the patients hospitalized in Beheshti hospital (Kashan-Iran). Feyz J Kashan Univers Med Sci. 2017;21(2):197-205.

16. Abdullah BB, Zoheb M, Ashraf SM, Ali S, Nausheen N. A study of community-acquired pneumonias in elderly individuals in Bijapur, India. ISRN Pulmonol. 2012;2012:1-10.

17. Kobashi Y, Okimoto N, Matsushima T, Soejima R. Clinical analysis of community-acquired pneumonia in the elderly. Intern Med. 2001;40(8):703-7.

18. Torres A, Dorca J, Zalacain R, Bello S, El-Ebiary M, Molinos L, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med. 1996;154(5):1456-61.

19. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, et al. Causes of death for patients with community-acquired Pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 2002;162(9):1059-64.

20. Hasibi M, Rasoulinejad M, Hosseini SM, Davari P, Sahebian A, Khashayar P. Epidemiological, clinical, laboratory findings and outcomes of disseminated tuberculosis in Tehran, Iran. South Med J. 2008;101(9):910-3.

21. Horatio BF, Monteagudo-Chu MO. community-Acquired pneumonia in the Elderly. Am J Geriatr Pharmacother. 2010;8(1):48-57.

22. Jafari S, Soltanpour F, Soudbakhsh A, Safavi E, Navipour R, Hajizadeh E. Community-Acquired Pneumonia: a Comparison between elderly and nonelderly patients. Tehran Univers Med J. 2006;64(8):74-80.

23. Berger A, Edelsberg J, Oster G, Huang X, Weber DJ. Patterns of initial antibiotic therapy for community-acquired Pneumonia in US hospitals, 2000 to 2009. Am J Med Sci. 2014;347(5):347-56.

24. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age-and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165(6):766-72.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.

Copyright (c) 2021 Authors

Downloads

Download data is not yet available.